| Original document(12 pages) 中文版 |
The invention discloses a tanshinoneIderivant and application in pharmacy, which is characterized by the following: the derivant constitutional formula is showed in the right chart: when R1 represents -Ar, R2,R3 represents hydrogen or alkyl with one to eight carbon atoms, cycloalkyl, aromatic nucleus or heterocyclic radical; or R2-N-R3 represents nitrogen saturation aza with nitrogen, imidazoline and its derivant, glyoxaline and its derivant, diethylenediamine and its derivant, piperidine and its derivant, morpholine and its derivant; when R1 represents -H, R2, R3 represents hydrogen and alkyl with three to eight carbon atoms, cycloalkyl, aromatic nucleus; or R2-N-R3 represents cyclohexylamine, imidazoline and its derivant, glyoxaline and its derivant, diethylenediamine derivant, piperidine derivant, morpholine derivant. The derivant can apply for preparing clinical preparation. |
Application Number
申请号 |
200610039932 |
Application Date
申请日 |
2006.04.26 |
| Title 名称 |
Tanshinone I derivatives and pharmaceutical application thereof
|
Publication Number
公开号 |
1837200 |
Publication Date
公开日 |
2006.09.27 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
C07D307/87,C07D405/06,A61K31/343,A61K31/496,A61K31/4178,A61K9/20,A61K9/48,A61K9/08,A61K9/19,A61P9/00,A61P9/10,A61P9/12,A61P7/02,A61P13/12,A61P27/02,A61P17/12 |
Applicant(s) Name
申请人 |
Qin Yinlin |
| Address 地址 |
210016 |
| Inventor(s) Name 发明人 |
|
| Attorney & Agent 代理人 |
|
|
|